Delivery Order SPE2DB22D1106-SPE2DB24FFCJ7

Award Date 7/16/24
Potential Completion Date 7/17/24
Potential Value $4.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the PEDVAXHIB vaccine in 0.5 milliliter vials. The $2,405.65 contract has a completion date of June 23, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, that enables the company to supply a wide range of pharmaceutical products and...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PEDVAXHIB VACCINE VIAL 0.5ML, with a ceiling value of $5,557.80 and a period of performance through December 17, 2024. The contract is a Firm Fixed Price arrangement, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PEDVAXHIB vaccine vials. The contract has a firm fixed price of $2,462.32 and a performance period through August 8, 2024. It is not a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $5,928.42 firm fixed-price contract is for the supply of the PEDVAXHIB vaccine in 0.5 ml vials. The contract has an ultimate completion date of August 29, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical supplies and medications to various federal agencies and healthcare programs. This order is...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,817.10 firm-fixed-price delivery order is for the supply of PEDVAXHIB vaccine vials. The contract has an ultimate completion date of December 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $8,636.50 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company. The contract is for the provision of PEDVAXHIB vaccine vials and has a completion date of February 14, 2024. This delivery order is issued under Amerisourcebergen's existing indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and a performance period through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the purchase of PEDVAXHIB vaccine vials. The contract has a ceiling value of $1,004.81 and a final completion date of February 21, 2025. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a $1,055.28 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the PEDVAXHIB vaccine in 0.5 mL vials, with a completion date of September 25, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities to support military...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The award is for the provision of PEDVAXHIB vaccine vials (0.5 ml) with a ceiling value of $4,021.82 and a performance period through April 9, 2024. This delivery order is placed under an existing indefinite delivery contract (IDC) awarded solely to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of the PEDVAXHIB vaccine in 0.5 mL vials, with a ceiling value of $7,583.60 and a completion date of February 26, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFCJ7
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the PEDVAXHIB vaccine in 0.5mL vials. The order, valued at $4,924.64, has a firm fixed price and an ultimate completion date of July 17, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, for delivering a broad range of medical commodities to support military treatment programs and facilities worldwide. This delivery order is part of that overarching IDC, which enables the DLA to efficiently procure essential pharmaceutical products from AmerisourceBergen to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 10/15/24, 9:34 PM